Regression of multiple intracranial meningiomas after cessation of long-term synthetic progesterone (megestrol) medication: case report and autopsy

Authors

  • Tamadar A. AlDoheyan Department of Pathology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Current appointment: Department Of Pathology, King Saud University, Riyadh, Saudi Arabia
  • Marc R. Del Bigio Department of Pathology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Pathology, Shared Health Manitoba, Winnipeg, Manitoba, Canada

DOI:

https://doi.org/10.17879/freeneuropathology-2024-5813

Keywords:

Autopsy, Meningioma, Megestrol, Progesterone receptor, Tumor involution

Abstract

We report the history of a woman who developed four intracranial meningiomas during 11 years of therapy with the synthetic progesterone agonist megestrol. After discontinuation of the drug at age 75 years, she improved clinically and a CT scan showed near complete regression of the meningiomas by 78 years. Autopsy was performed at 83 years of age following an accidental death. At the tumor sites, we found both collagenous tissue with small islands of low grade meningioma having strong nuclear immunoreactivity for progesterone receptor and lipomatous tissue. A literature review showed similar cases of radiologic meningioma regression following discontinuance of progestins. Our case is the first one with histopathologic characterization of the end point.

Metrics

PDF views
320
Oct 31 '24Nov 01 '24Nov 04 '24Nov 07 '24Nov 10 '24Nov 13 '24Nov 16 '24Nov 19 '24Nov 22 '24Nov 25 '249
|
HTML views
78
Oct 31 '24Nov 01 '24Nov 04 '24Nov 07 '24Nov 10 '24Nov 13 '24Nov 16 '24Nov 19 '24Nov 22 '24Nov 25 '245.0
|

Downloads

Published

2024-10-29

How to Cite

AlDoheyan, T. A., & Del Bigio, M. R. (2024). Regression of multiple intracranial meningiomas after cessation of long-term synthetic progesterone (megestrol) medication: case report and autopsy. Free Neuropathology, 5, 27. https://doi.org/10.17879/freeneuropathology-2024-5813

Issue

Section

Case Reports